Publications by authors named "Thorsten Petrich"

Claim this Profile
H
High-risk patients with differentiated thyroid cancer T4 primary tumors achieve remnant ablation equally well using rhTSH or thyroid hormone withdrawal.
Peter Bartenstein, Elisa Caballero Calabuig, Carlo Ludovico Maini, Renzo Mazzarotto, M Angustias Muros de Fuentes, Thorsten Petrich

Thyroid· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lesion dose in differentiated thyroid carcinoma metastases after rhTSH or thyroid hormone withdrawal: 124I PET/CT dosimetric comparisons.
Lutz Stefan Freudenberg, Walter Jentzen, Thorsten Petrich, Cornelia Frömke, Robert J Marlowe

Eur J Nucl Med Mol Imaging· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncofetal fibronectin mRNA is highly abundant in the blood of patients with papillary thyroid carcinoma and correlates with high-serum thyroid-stimulating hormone levels.
Michael Wehmeier, Thorsten Petrich, Korbinian Brand, Ralf Lichtinghagen, Eric Hesse

Thyroid· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro experimental (211)At-anti-CD33 antibody therapy of leukaemia cells overcomes cellular resistance seen in vivo against gemtuzumab ozogamicin.
Thorsten Petrich, Zekiye Korkmaz, Doris Krull, Cornelia Frömke, Geerd J Meyer

Eur J Nucl Med Mol Imaging· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography.
Eric Hesse, Eckart Moessinger, Herbert Rosenthal, Florian Laenger, Georg Brabant, Thorsten Petrich

J Bone Miner Res· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective cancer therapy with the alpha-particle emitter [211At]astatine in a mouse model of genetically modified sodium/iodide symporter-expressing tumors.
Thorsten Petrich, Leticia Quintanilla-Martinez, Zekiye Korkmaz, Elenore Samson, Hans Jürgen Helmeke

Clin Cancer Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis